A role for membrane shape and information processing in cardiac physiology by Ralph Knöll
INVITED REVIEW
A role for membrane shape and information processing
in cardiac physiology
Ralph Knöll
Received: 9 April 2014 /Revised: 28 June 2014 /Accepted: 2 July 2014 /Published online: 17 August 2014
# The Author(s) 2014. This article is published with open access at Springerlink.com
Abstract While the heart is a dynamic organ and one of its
major functions is to provide the organism with sufficient
blood supply, the regulatory feedback systems, which allow
adaptation to hemodynamic changes, remain not well under-
stood. Our current description of mechanosensation focuses
on stretch-sensitive ion channels, cytoskeletal components,
structures such as the sarcomeric Z-disc, costameres, caveo-
lae, or the concept of tensegrity, but these models appear
incomplete as the remarkable plasticity of the myocardium
in response to biomechanical stress and heart rate variations
remains unexplained. Signaling activity at membranes depends
on their geometric parameters such as surface area and curva-
ture, which links shape to information processing. In the heart,
continuous cycles of contraction and relaxation reshape mem-
brane morphology and hence affect cardio-mechanic signaling.
This article provides a brief review on current models of
mechanosensation and focuses on how signaling, cardiac
myocyte dynamics, and membrane shape interact and poten-
tially give rise to a self-organized system that uses shape to
sense the extra- and intracellular environment. This novel con-
cept may help to explain how changes in frequency, and thus
membrane shape, affect cardiac plasticity. One of the conclu-
sions is that hypertrophy and associated fibrosis, which have
been considered as necessary to cope with increased wall stress,
can also be seen as part of complex feedback systemswhich use
local membrane inhomogeneity in different cardiac cell types to
influence whole organphysiology and which are predicted to
fine-tune and thus regulate membrane-mediated signaling.
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Introduction
Heart failure is the leading cause of death worldwide [29].
While we continue to unravel the genetic basis of heart failure
and while the equilibrium between cardiomyocyte cell loss
and regeneration is severely damaged in heart failure, the
functional link between both and how mechanical forces
influence these events remains poorly understood [33]. Al-
though the force–frequency relationship, which is an intrinsic
property of cardiac muscle resulting in increased force pro-
duction at higher frequencies, has been described more than a
century ago, we are still unable to fully understand this phe-
nomenon (for a recent review: Puglisi et al. [36]). In addition,
cardiac hypertrophy and its reverse, cardiac atrophy, are trig-
gered, among others, by an increase or decrease in physical
stress, respectively, which are also inherently linked to chang-
es in frequency and hence membrane shape. At the organ
level, all of these changes lead to significant remodeling
processes, which not only affect cardiac myocytes but
also other cell types inherent to the myocardium, the
composition of the extracellular matrix (ECM) and of
course processes such as angiogenesis [21].
Striated muscle cells such as cardiac myocytes, in contrast to
other cell types, produce massive forces and as such are not
only sensitive to external but also internal stimuli. It is clear that
this force production needs to be fine-tuned and well controlled
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to avoid dysfunction. This aspect of mechanosensation can be
called intracellular mechanosensation in contrast to the well-
known perception of mechanical forces from outside the cell.
Both effects must be linked, but the underlying molecular
mechanisms remain so far unknown [24].
With a molecular mass of up to 4.2 MDa, titin is the largest
protein known in biology. It spans from the sarcomeric Z-disc
to the M-line and is directly involved in the sensation and
transmission ofmechanical stimuli, where titin’s I-band region
may function as a length sensor (ε = ll0 Þ, while titin’s Z-disc
domain may be involved in the sensation of stress (σ ¼ FAÞ
[6]. The underlying molecular mechanisms remain poorly
defined, but titin interacts at the sarcomeric Z-disc with
telethonin or TCAP, which is linked to a striated-muscle-
specific, mechanosensitive survival pathway and which can
be called mechanoptosis [23]. Mutations in components of the
sarcomeric Z-disc are well-known causes of various diseases
(i.e., Z-discopathies [18]), including cardiomyopathies [5, 20,
22], and the above-mentioned pathway may well play a role.
An increase in volume (i.e., stretch) is well known to
influence the frequency and the regulatory of the beating heart
[28], an effect known as mechanoelectrical feedback, and this
change in frequency almost certainly will have effects on
elastic components of the heart, including titin’s I-band re-
gion, and titin’s ability to interact with binding partners [42]
and hence will affect its mechanosensory role. In contrast, an
increase in pressure most likely primarily affects Z-disc-
mediated signaling, an effect which involves Z-disc transcrip-
tional coupling [18, 19]. Truncating titin mutations, which can
be found in up to 30% of dilated cardiomyopathy patients, but
also—albeit at a lower frequency of 3 %—in the general
population, are thought to be a cause for this type of heart
failure [15]. The recently identified molecular mechanism,
whereby S-glutathionylation of cryptic cysteins enhances titin
elasticity by inhibiting protein folding, may help to understand
the underlying pathology and extend our knowledge in regard
to effects of missense mutations in this gene. Different signal
transduction cascades initiated via titin or the Z-disc may
contribute to the development of eccentric and concentric
types of hypertrophy observed after volume and pressure
overload, respectively. However, our knowledge remains poor
in regard to the precise identification of these pathways and
how they affect the frequency of the beating heart and hence
membrane shape.
Heart failure, cardiac plasticity, and mechanical forces
At the cellular level, cardiac hypertrophy and atrophy are
associated with an increase or decrease in cardiac myocyte
(or organ) size, respectively, which (alone) poses a tremen-
dous challenge for every cell. These changes are particularly
important for cardiac myocytes not only because new
sarcomeres have to be added or removed (positive or negative
growth in three dimensions) but also because membrane con-
stituents have to increase or decrease respectively (positive or
negative growth in two dimensions). However, due to tran-
scription factor overlap (i.e., there are no specific sets of
transcription factors available to separately regulate the tran-
scription of membrane or cellular components), membrane
and cellular components have to change proportionately, and
a new equilibrium has to be found, which is only possible
within certain limits. Therefore, it is no surprise that lethality
after myocardial infarction is highest immediately in the days
after the incident where remodeling occurs [39], but the feed-
back mechanisms which link the membrane to remodeling
processes remain largely unexplained.
Hypertrophy, within limits and if reversible, might initially
be beneficial. However, in the long run (months and years),
most likely every hypertrophy is pathological, even in ath-
letes, and no signal transduction pathway is necessarily adap-
tive or maladaptive, rather the strength and/or the nature
of the stimulus determine the outcome (i.e., persistent
such as in aortic constriction or intermittent such as
during exercise) [21].
Several different but intertwined mechanosensory mecha-
nisms are active in cardiomyocytes (Table 1).
Another way to understandmechanosensation is to introduce
tensegrity (Table 2), which describes a concept whereby ele-
ments are either under tension (such as the muscles in our body)
or in compression (such as the bones) and which has profound
consequences for cell biology as it implies that nearly every
protein, either directly or indirectly, is involved in processing
mechanical information (Table 2). Therefore, naturally occur-
ring mutations or complete loss of these components, such as
those observable in genetically altered animals, are expected to
affect the perception of biomechanical stress, which in the most
cases is true.
Membrane-mediated mechanosensation
The plasma membrane separates the “living” cytoplasm from
the outside, serves as a selective barrier, and also integrates the
Table 1 Summary of current mechanosensory concepts and structures
1. Transmembrane proteins and membrane-associated complexes
(a) mechanosensitive ion channels (i.e., some channels are activated,
while others are inactivated by cell stretch)
(b) integrins and the dystrophin-associated glycoprotein complex
(c) structures: caveolae
(d) enzymes: receptor tyrosine kinase (mitogen-activated protein kinase
(MAPK))
2. Protein–protein interaction-mediated processes (posttranslational
modifications)
3. Sarcomere-related mechanosignaling, including titin (length sensor),
actomyosin interaction, AMPK, and Z-disc (tension sensor)
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internal cytoplasm with the surroundings by initiating specific
signal transduction cascades. By doing so, it allows efficient
biochemical signaling primarily via dimensionality reduction
in the diffusible space of protein reactants [1]. In addition, the
cell membrane not only provides a two-dimensional surface
area but also acts as a deformable material whose interaction
with the cytoskeleton leads to changes in membrane shapes, a
property important for the catalysis of chemical reactions [37].
In cardiac myocytes, the membrane connects to the cytoskel-
eton (i.e., sarcomeric Z-discs) at structures called costameres,
a well-known hot spot for signaling (for an excellent recent
review, see Samarel [38]).
According to the law of mass action,
K ¼ C½  D½ 
A½  B½ 
the product of the rate of random collisions of the reactants
and the probability that a collision will lead to binding deter-
mine the kinetics of a signaling reaction. Or in other words,
the concentration of the reactants and the rate constant, which
includes the summed diffusion speed and the probability that a
collision will lead to binding, determine the kinetics.
The concentration of reactants and hence collision frequen-
cy are dramatically increased when diffusible space is reduced
from three dimensions in the cytosol to two dimensions on the
membrane, which has been shown by Kholodenko and co-
workers especially for receptor tyrosine kinase (RTK) medi-
ated signaling [17]. Nevertheless, the increase in concentra-
tion is accompanied by a reduction in the diffusional mobility
of the reactants. Whether dimensionality reduction provides a
gain in the reaction rate has been analyzed for extracellular
ligands by Axelrod and Wang, and the authors concluded that
reaction rates do increase, although the mobility of the reac-
tants is decreased [4].
Particularly, RTK-Ras signaling has been studied in this
context. Ras is a GTPase and not only is a major oncogenic
signaling protein but also involved in hypertrophic and sur-
vival signaling of cardiac myocytes.
Ras interacts with and thereby recruits effectors to the
plasma membrane only when activated by guanine nucleotide
exchange factors (GEFs). These factors form complexes with
adaptor proteins binding to activated RTKs, and activated Ras
GTP will recruit and concentrate effectors such as BRaf. BRaf
itself is activated in asymmetric dimers containing activator
kinase that induces cis-autophosphorylation in the activation
loop of the receiver kinase [16]. Interaction of BRaf with Ras
triggers a conformational change to allow the asymmetric
dimerization to occur and enhances BRaf dimerization [34]
using the above-mentioned dimensionality reduction. Phos-
phorylation of CRaf, which is also able to interact with Ras
[14], in the N-terminal acidic motif by membrane-associated
kinases such as Src [11] or protein kinase C (PKC) [26] allows
it to become the activator kinase in asymmetric dimers [9].
PKC is recruited to the plasma membrane by the lipid second
messenger diacylglycerol, and most of PKC isoforms are
activated by calcium, thus linking CRaf phosphorylation to
calcium transients in cardiac myocytes. There are even more
direct links to mechanosensation as Src kinase, which to a
large extent transmits integrin-mediated signals and which
localizes to costameres, can also be viewed as a mechanically
induced kinase [45] and which has been shown to phosphor-
ylate p130Cas upon stretch [40].Moreover, Ras mutations are
a well-known cause of LEOPARD and Noonan syndromes,
which are characterized by skin, skeletal, and cardiovascular
defects, which include syndromic forms of hypertrophic car-
diomyopathy and which are called RASopathies (for a review:
Gelb and Tartaglia [13]).
In summary, the ERK1/2 pathway is particularly important
in the heart as it integrates both growth and cell survival,
depending on the prevailing amount and nature of biomechan-
ical stress [30]. CRaf and its activating kinases are
translocated and concentrated on the sarcolemma, which
largely increases the kinetics of CRaf aminoterminal phos-
phorylation and the propagation of signals via the MAPK
pathway.
Taking into account membrane curvature
The above-mentioned concepts do not take into account in-
homogeneity in membrane curvature, which may also affect
protein association and hence signaling. It is reasonable to
assume that in cavities—where high surface to cytosol ratios
exist—local resupply via diffusion is limited. Exactly the
opposite should happen for protruding membrane folds that
have a low local surface to cytosol ratio and where a large
diffusible cytosolic pool is available.
Precisely, these effects have recently been studied, and a
theory of this concept of locality of surface to volume ratios
has been developed, and it was shown that this operates in
signaling [37]. Rangamani and coworkers combined (1) reac-
tion kinetics, (2) diffusion, and (3) membrane shape and
showed how a transient enhancement of receptor activity after
increased ligand binding in curved plasma membrane areas
can mediate enhancement of MAPK or Src kinase activity in
downstream signaling pathways. In other words, information
contained in a cell’s shape can be transformed into different
biochemical signaling activities. This effect, of course, is short
Table 2 Summary of localized versus tensegrity-based models of signal
transduction
1. Localized signal transduction (i.e., the signal is generated in close
proximity to the perceived stimulus)
2. Tensegrity (i.e., the stimulus is transmitted before being translated into
a biochemical signal)
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lived as diffusion will equilibrate ligand-induced inhomoge-
neity of receptor activity but may well play a more prominent
role in dynamic systems such as the heart.
Applications of the concept of locality of surface to volume
ratios
The above-described effect of locality of surface to volume
ratios may play a role in endocytosis, where maximized
signaling activity of endocytosed RTKs has been observed
[43], or it may play a role in mitochondria, where cristae
morphology determines assembly and activity of the respira-
tory chain complexes (for a recent review please, see Schmick
and Bastiaens [41]).
This effect also might be important for differentiating em-
bryonic stem cells, where in mesenchymal stem cells, spread-
ing has been shown to give rise to osteocytes, whereas round
cells evolved into adipocytes. In this set of experiments, cell
shape has been shown, at least to some extent, to determine
the activity of the RhoA-ROCK pathway [31].
Local membrane inhomogeneity may also play a role in
dynamic organs such as the heart, where cardiac myocytes
change their shape frequency dependent and drag or release
other cell types resident in the heart such as cardiac fibroblasts.
Cardiac fibroblasts are the primary producers of ECM in the
heart and cardiac myocyte—cardiac fibroblast communica-
tion plays a major role in many cardiovascular diseases such
as hypertrophy, hypertension, and coronary heart disease (for
a review: Fujiu and Nagai [12]).
Cardiac myocytes and cardiac fibroblasts are highly inter-
spersed in the myocardium with several fibroblasts surround-
ing a single myocyte. Bidirectional cross talk between these
cell types plays important roles in determining cardiac me-
chanical and electrical function in normal and diseased hearts.
Mechanisms involved include the release of paracrine factors
such as TGFβ, IL family members, TNFα, VEGF, FGF2,
endothelin, and AngII; direct cell–cell interactions via gap
junctions and possibly adherence junctions and nanotubes;
and interactions with the ECM (for an excellent review: Zhang
et al. [46]). VEGF seems to be of particular importance as it
can be secreted from injured cardiac myocytes and which, in
turn, acts as a paracrine factor to induce myofibroblast prolif-
eration, suggesting that VEGF also contributes to fibrosis in
the diseased heart [35]. In addition, the importance of TGFβ
for hypertrophic cardiomyopathy and associated fibrotic re-
modeling processes has recently been demonstrated [44]. The
recent observation of gap junctions existing between cardiac
fibroblasts and cardiac myocytes, which most likely play a
role in the prevention of arrhythmias, is certainly remarkable
and will provide new impetus for therapy [3, 32].
Cardiac fibroblasts will, depending on the frequency of the
beating heart, periodically elongate and shrink. High frequen-
cies are predicted to increase the probability of a fibroblast
being in elongation and thus sensitize the cell to growth factor
stimulation.
Local inhomogeneity of the membrane could also explain
why some preexcitation syndromes, which are associated with
periodic increases in frequency, appear hypertrophic and de-
velop fibrosis [2]—an effect probably related to cardiac fibro-
blasts, which also have been studied in the report by
Rangamani and coworkers [37].
Aside from RTKs such as epidermal growth factor receptor
(EGR), which couples to Ras, or Src kinase, and costamere-
related signaling, beta adrenergic receptors (βARs) are very
important for cardiac physiology as they convey positive
inotrope, bathmotrope, lusitrope, and chronotrope signals.
One of the oldest and probably best analyzed heart failure
models used in physiology is the pacing-induced heart
failure model in dogs [10]. While contraction may provide
costameres with more diffusional space and thus enhance
signaling via these structures in systole, βARs are likely to
be equally distributed over the sarcolemma, and therefore,
βAR-mediated signaling is more likely to seize, which is
exactly what has been observed in pacing-induced heart
failure [7].
A βAR-mediated increase in frequency, via changes in
membrane shape alone, is expected to activate the Ras–Raf–
MAPK pathway and hence to initiate a pro-hypertrophic and
pro-apoptotic pathway, while βAR activation is probably
attenuated (Fig. 1).
Another consequence of this effect probably can be directly
related to cardiac myocytes. Stretched and therefore elongated
cardiac myocytes show an increase in MAPK kinase activity
such as an upsurge in ERK1/2 phosphorylation, which has
been linked to angiotensin II (Ang II) and angiotensin II type 1
receptor (AT1R) mediated effects [8]. However, the model of
local membrane inhomogeneity predicts that lengthened car-
diac myocytes are more prone to receptor mediated and
thus AT1R-mediated effects. In this context, it is probably
important to refer to the report by Zou and coworkers who
showed that mechanical stretch alone is sufficient to acti-
vate the AT1R [47], thus providing a positive feedback
mechanism for stretch-mediated effects, at least in cardiac
myocytes. Cyclic stretch in vitro in one dimension can be
related to volume overload in vivo, and local membrane
inhomogeneity may well be related to eccentric types of
cardiac hypertrophy.
It is probably worth pointing out that the dynamics of the
heart are a good example to study the effects of local mem-
brane inhomogeneity, as the surface areas and volumes of the
cells remain constant, which is difficult to prove in the exper-
imental settings used in the original article by Ramagani et al.
[37]. However, the effect of cardiac myocyte shape on func-
tion has recently been studied in an elegant article by Kuo and
coworkers [27]. The authors used in vitro assays to analyze
different aspect ratios (i.e., length/width ratios) and found that
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function clearly depended on the shape of the cardiac
myocytes and that shape also determined calciummetabolism.
Summary
In a simplified model, one can assume that a convex mem-
brane fosters ligand/receptor interaction and hence signaling.
Therefore an elongated, elliptical cell will increase its signal-
ing activity via decreasing local membrane to volume ratios.
These effects probably can be observed in the myocardium,
where contracting myocytes periodically elongate cardiac fi-
broblasts and hence increase their sensitivity to receptor-
mediated effects and which leads to hypertrophy in these cells.
An increase in frequency will increase the probability of a
cardiac fibroblast being elongated, being activated, and being
able to cause cardiac myocyte hypertrophy via cross talk. Or
in other words, cardiac fibroblasts will elongate in response to
stretch caused by contracting cardiac myocytes which, in turn,
will cause hypertrophy (first in cardiac fibroblasts and via
cross talk secondarily in cardiac myocytes).
The situation in cardiac myocytes itself probably is more
complex: Contraction will expose costameres to the cyto-
plasm and hence increase this type of signaling (for example,
integrin-mediated signaling such as Src kinase, focal adhesion
kinase, and integrin-linked kinase [25]). However, the mem-
brane parts between costameres probably are bulging out-
ward, which will increase membrane to cytosol ratios and
a
b
Fig. 1 a Heart failure is
associated with an increase in wall
stress as a result of increased
cardiac dimensions and loss of
wall thickness, which will stretch
all myocardial cells, as
schematically shown for a cardiac
fibroblast. b Cardiac myocytes
contract and enlarge periodically
during systole and diastole,
respectively. This will specifically
affect cardiomyocyte membrane
shapes: During systole costameres
are more exposed to the cytosol,
which will increase this type of
signaling. Parts of the membranes
between neighboring Z-discs
bulge out and thus increase local
membrane to volume ratios,
which is predicted to decrease
RTK-mediated signaling (and vice
versa in diastole)
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hence decrease signaling. Higher frequencies will result in a
net increase of costamere-related signaling and thus can con-
tribute to the development of (a certain type of) cardiac
myocyte hypertrophy and heart failure [10]. The development
of heart failure in other models, such the ones whereby an
increase in cardiac preload or volume stretches cardiac
myocytes and noncardiac myocytes, and which cause eccen-
tric hypertrophy, probably can be better explained by using the
concept of local membrane inhomogeneity.
Another aspect of this model is that every hypertrophy will
lead to a decrease of surface to volume ratios which increases
signaling activity, at least in theory. In the heart, this is expected
to cause diastolic defects, decrease the ability of the heart to
increase its frequency, and hence may lead to a termination of
costamere-related hypertrophic stimuli. Thus, hypertrophy can
be regarded as part of a negative feedback loop aimed to equil-
ibrate various membrane-mediated signaling pathways. The ef-
fects of local membrane inhomogeneity offer a novel molecular
mechanism to explain various types of cardiac hypertrophy,
which so far largely has been seen as a response to normalize
wall stress.
Although the concept of locality of surface to volume ratios is
attractive, it is still very general and to a large extent based on
theoretical considerations which depend on specific reaction
kinetics and diffusion probabilities and which may differ from
receptor to receptor, ligand to ligand, and cell-type to cell-type. In
addition, when introducing the concepts of hypertrophy and
atrophy, time and adaptation to the change in conditions have
to be considered. Additional experimental proof is needed, par-
ticularly in the cardiovascular system. Nevertheless, this effect
could be important for the heart.
Conclusion
Mechanosensation is a fundamental process and present in
every living cell with particular importance for a dynamic organ
such as the heart. Many different mechanosensory mechanisms
are at play in cardiac myocytes and include stretch activated (or
inactivated) channels, cytoskeletal components or structures
such as the sarcomeric Z-disc, or actomyosin interaction per se.
Recently, a novelmechanism has been describedwhereby cell
shape directly translates into signaling and which might be of
importance particularly for the heart where cells during systole
and diastole continuously reshape membranes. The concept of
locality of surface to volume ratios was demonstrated to affect
membrane-mediated signaling and may help to explain the re-
markable plasticity of the myocardium in response to biome-
chanical stress.
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